Biologics Price Competition and Innovation Act [Minnesota Journal of Law, Science and Technology]

Ude Lu, a member of Cozen O'Connor's Intellectual Property Department, discusses Biologics Price Competition and Innovation Act (BPCIA) in the Minnesota Journal of Law, Science, and Technology. The central mission of the BPCIA is two-fold: (1) providing sufficient incentives for continuous innovations in biologic therapies and (2) lowering the price of biologic therapies. 

To read the article, click here.


Share Page On LinkedIn